Zymo Analysis Company, a frontrunner in modern life science options, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, on the US District Court docket for the Central District of California concerning its MAGicBead cfDNA isolation know-how. Zymo Analysis respects mental property rights and is assured that this know-how represents a major development in nucleic acid purification.
“Our MAGic cfDNA purification system is a groundbreaking innovation,” mentioned Dr. Larry Jia, Founder and CEO of Zymo Analysis. “Whereas this authorized problem locations a major burden on our assets as a small firm, our dedication to the scientific neighborhood is stronger than ever.”
For over 30 years, Zymo Analysis, an organization of “Scientists for Scientists,” has delivered modern options to satisfy the evolving wants of researchers. Regardless of being a modestly sized firm with round 250 workers, Zymo Analysis provides cutting-edge options from genetic, epigenetic, and microbiomic analysis instruments to eco-friendly pattern transport options. That is owed to prioritizing a tradition of innovation, high quality, and customer support.
“Our success is rooted within the belief of our clients and researchers worldwide,” mentioned Dr. Marc Van Eden, VP of Company Improvement. “We’re dedicated to giving again to the neighborhood with the perfect, most modern merchandise.”
Regardless of this authorized problem, Zymo Analysis stays targeted on its mission of advancing life science with dependable options trusted by 1000’s of researchers globally and serves as a reminder of their unwavering dedication to science and the betterment of humanity.
